About Brainomix

Brainomix’s vision is to become a world leader in imaging software to support clinical decision making, for neurological and cerebrovascular diseases.

An expert team of clinicians, stroke neurologists, scientists, business professionals and engineers, has a collective wealth of experience that makes Brainomix ideally positioned to serve the clinical community.

“We help clinicians making life-saving treatment decisions by supporting the selection of the right treatment for the right stroke patient”

Dr Michalis Papadakis, CEO

Since Brainomix’s launch, as a spin-out from the University of Oxford in 2010, it has developed the CE-marked, award-winning stroke imaging software, e-ASPECTS. Its product supports stroke physicians in fast, consistent diagnosis for ischemic stroke by automatically implementing the validated clinical scoring methodology, Alberta Stroke Programme Early CT Score (ASPECTS). The company aims to continue to help clinicians worldwide, in the timely identification of patients eligible for life saving treatment in stroke.

  • Decades of collective experience in stroke neurology
  • Exceptional in-house clinical expertise
  • Expert technical support